Related Experiment Videos

Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management

Iliana Alexoudi1, Meletios Kanakis, Violetta Kapsimali

  • 1University of Athens, Internal Medicine, 17 St. Thomas St., 11527, Athens. aleiliana@yahoo.gr

Autoimmunity Reviews
|May 10, 2011
PubMed

Insights

Early recognition of Kawasaki disease (KD), a childhood vasculitis, is crucial to prevent coronary artery aneurysms. Management and long-term follow-up are tailored to disease stage and individual risk factors.

Area of Science:

  • Pediatric Rheumatology
  • Vasculitis Research
  • Immunology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • It primarily affects children aged 6 months to 4 years.
  • Delayed diagnosis can lead to severe cardiac complications, including coronary artery aneurysms.

Purpose of the Study:

  • To emphasize the importance of early Kawasaki disease recognition.
  • To outline current understanding of KD's aetiopathogenesis.
  • To describe the principles of KD management and long-term follow-up.

Main Methods:

  • Review of epidemiological, laboratory, and histological data.
  • Analysis of clinical staging for disease management.
  • Assessment of risk stratification for patient follow-up duration.

Main Results:

  • Kawasaki disease requires prompt identification to mitigate inflammatory processes.
  • The etiology of KD remains unknown, with ongoing research into its causes.
  • Treatment strategies are individualized based on clinical presentation and risk.

Conclusions:

  • Early diagnosis and intervention are paramount in managing Kawasaki disease.
  • Comprehensive, long-term patient monitoring is essential, guided by risk assessment.
  • Further research into KD's causative agent is needed to improve prevention and treatment.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...